Search results
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
AOL· 6 days agoThe therapy is currently in late-stage development for the treatment of pulmonary arterial hypertension (PAH), which affects about 40,000 people in the United States. While the company has not ...
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
Zacks via Yahoo Finance· 3 days agoThis compares with our projection of $15.8 million in revenues. The company had recorded a...
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks via Yahoo Finance· 4 days agoThe upside was driven by increased royalties from Amgen’s Kyprolis, Jazz Pharmaceuticals’ Rylaze, ...
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoMersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript May 9, 2024 Mersana...
Cervical Cancer Can Be Eliminated. Alabama Is Leading the Way.
The Wall Street Journal· 7 days agoDoctors are rallying around an audacious goal: eliminating a cancer for the first time. Cervical...
Chiesi buys into Gossamer’s Winrevair rival, betting almost $500M
FierceBiotech· 6 days agoGossamer is currently enrolling a phase 3 seralutinib study for patients with PAH, the same...
Futures Fall As Shopify, Uber Dive On Earnings
Investor's Business Daily· 4 days agoOther key earnings movers include Arista Networks, Lyft, Reddit and Toast.
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 6 days agoHe writes frequently about the blockbuster potential of ponsegromab, which Pfizer is testing as a...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Reuters· 6 days agoGossamer Bio said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and...
Dow Scores Six-Day Winning Streak Amid Fed Officials Fears; Tesla Falls On Latest Probe
Investor's Business Daily· 4 days agoDepartment of Commerce pulled back a license to export goods to China. Intel stock skidded 2.2% to...